01177 SINO BIOPHARM
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.26X | Oper Margin | 25.6% |
|---|---|---|---|
| LT Debt/Equity | 6.5% | Net Margin | 12.1% |
| Total Debt/Equity | 30.4% | Return on Equity | 11.0% |
| Price/Book | 4.98X | Return on Assets | 5.4% |
| (HKD 9.010) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 3,722.07 | 2,570.26 | 2,851.85 | 17,867.55 | 3,288.72 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +44.8 | -9.9 | -84.0 | +443.3 | +6.5 |
| Earnings Per Share (HKD) | 0.204 | 0.139 | 0.153 | 0.952 | 0.175 |
| Earnings Per Share Growth (%) | +46.7 | -9.4 | -83.9 | +444.3 | +6.6 |
| Dividend Per Share (HKD) | 0.070 | 0.050 | 0.120 | 0.080 | 0.073 |
| P/E* (X) | 44.28 | 64.96 | 58.85 | 9.46 | 51.52 |
| Yield (%) | 0.78 | 0.55 | 1.33 | 0.89 | 0.81 |
| Dividend Share (%) | 34.40 | 36.05 | 78.38 | 8.40 | 41.91 |
| Book NAV (HKD) | 1.809 | 1.787 | 1.773 | 1.967 | 1.054 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-08 21:40:20
Latest Result
| (RMBMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
| Cover Period (mths) | 6 | 6 | NA | 6 |
|---|---|---|---|---|
| Turnover | 17,575 | 15,928 | +10.3 | 15,277 |
| Operating Result | 5,970 | 3,713 | +60.8 | 3,371 |
| Associates | -4.823 | -93.056 | -94.8 | -219.438 |
| Profit Before Taxation | 5,967 | 5,331 | +11.9 | 3,224 |
| Taxation | 981.324 | 724.236 | +35.5 | 524.743 |
| Profit /( Loss) After Taxation | 4,986 | 4,607 | +8.2 | 2,699 |
| Minority Interests | 1,597 | 1,590 | +0.4 | 1,441 |
| Net Profit | 3,389 | 3,017 | +12.3 | 1,259 |
| Earnings Per Share () | 0.2062 | 0.1761 | +17.1 | 0.0732 |
| Dividend Per Share () | 0.0500 | 0.0300 | +66.7 | 0.0200 |
| Announcement Date | 2025-08-18 | 2024-08-13 | NA | 2023-08-25 |
* Annualised
Last Update Time: 2025-09-08 21:40:25
